Works matching IS 10538569 AND DT 2025 AND VI 34 AND IP 2

Results: 23

Opioid Use After Hip Fracture and Subsequent Fracture Outcomes: A Self‐Controlled Case Series Design.
Published in:
Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 2, p. 1, doi. 10.1002/pds.70118
By:
- Cupp, Meghan A.;
- Hayes, Kaleen N.;
- Berry, Sarah D.;
- Beaudoin, Francesca L.;
- Riester, Melissa R.;
- Joshi, Richa;
- Zullo, Andrew R.
Publication type:
Article
Geographic and Temporal Patterns in Biologic Prescriptions for Inflammatory Bowel Diseases in the Public Healthcare System in Brazil: An Ecological Study.
Published in:
Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 2, p. 1, doi. 10.1002/pds.70114
By:
- de Castro, Caroline Tianeze;
- dos Santos Natividade, Marcio;
- Pereira, Marcos;
- Miranda, Samilly Silva;
- Aragão, Erika;
- de Souza Teles Santos, Carlos Antonio;
- dos Santos, Djanilson Barbosa
Publication type:
Article
Utilisation Trends of Lisdexamfetamine: Insights From Recent Medicine Shortages in Australia.
Published in:
Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 2, p. 1, doi. 10.1002/pds.70113
By:
- Janetzki, Jack;
- Kalisch, Lisa;
- Hall, Kelly;
- Pratt, Nicole
Publication type:
Article
Evaluating the Role of High‐Dimensional Proxy Data in Confounding Adjustment in Multiple Sclerosis Research: A Case Study.
Published in:
Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 2, p. 1, doi. 10.1002/pds.70112
By:
- Karim, Mohammad Ehsanul;
- Hossain, Md. Belal;
- Ng, Huah Shin;
- Zhu, Feng;
- Frank, Hanna A.;
- Tremlett, Helen
Publication type:
Article
Evaluating the Accuracy of Responses by Large Language Models for Information on Disease Epidemiology.
Published in:
Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 2, p. 1, doi. 10.1002/pds.70111
By:
- Zhu, Kexin;
- Zhang, Jiajie;
- Klishin, Anton;
- Esser, Mario;
- Blumentals, William A.;
- Juhaeri, Juhaeri;
- Jouquelet‐Royer, Corinne;
- Sinnott, Sarah‐Jo
Publication type:
Article
The Healthcare Integrated Research Database (HIRD) as a Real‐World Data Source for Pharmacoepidemiologic Research.
Published in:
Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 2, p. 1, doi. 10.1002/pds.70110
By:
- Barron, John J.;
- Willey, Vincent J.;
- Doherty, Brett T.;
- Tunceli, Ozgur;
- Waltz, Craig R.;
- Grabner, Michael;
- Beachler, Daniel C.;
- Lanes, Stephan;
- Cziraky, Mark J.
Publication type:
Article
Adapting the European Concerted Action on Congenital Anomalies and Twins (EUROCAT) Guide 1.5 for Use in Post‐Authorisation Safety Studies Using US Data.
Published in:
Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 2, p. 1, doi. 10.1002/pds.70109
By:
- Hoffman, Sarah Ruth;
- Kalloo, Geetika;
- Lanes, Stephan;
- Jamal‐Allial, Aziza;
- Sponholtz, Todd;
- Brooks, Corinne;
- Guzman, Maria;
- Van Rompay, Maria I.;
- Onasanya, Oluwadamilola;
- Willey, Vincent J.;
- Foster, Erica;
- Messeh, Nadia;
- Layton, Jill;
- Ponist, Dawn;
- Noan‐Lainé, Maryline L. E.;
- Schroeder, Krista
Publication type:
Article
Impact of Regulatory Action on Dose Maximalization for Vitamin B6 Dietary Supplements on the Reporting Pattern for Neuropathy.
Published in:
Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 2, p. 1, doi. 10.1002/pds.70108
By:
- van Hunsel, Florence;
- Scholl, Joep;
- Vrolijk, Misha;
- Ekhart, Corine
Publication type:
Article
Impact of Antibiotic Shortages on Antibiotic Utilisation in the Community.
Published in:
Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 2, p. 1, doi. 10.1002/pds.70107
By:
- Lambert, Maarten;
- Taxis, Katja;
- Pont, Lisa
Publication type:
Article
Expanding the OMOP Common Data Model to Support Perinatal Research in Network Studies.
Published in:
Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 2, p. 1, doi. 10.1002/pds.70106
By:
- Abellan, Alicia;
- Burn, Edward;
- Trinh, Nhung T. H.;
- Burkard, Theresa;
- Callahan, Alison;
- Fernández‐Bertolín, Sergio;
- Hurley, Eimir;
- Rodriguez, Clara;
- Segundo, Elena;
- Morales, Daniel R.;
- M. E. Nordeng, Hedvig;
- Duarte‐Salles, Talita
Publication type:
Article
The Effect of Isoniazid for Tuberculosis Prevention on Pregnancy Risk Among Women Living With HIV on Antiretroviral Treatment and Progestin‐Based Hormonal Contraception.
Published in:
Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 2, p. 1, doi. 10.1002/pds.70105
By:
- Diepstra, Karen;
- Westreich, Daniel;
- Bula, Agatha;
- Lemani, Clara;
- Chapola, John;
- Winston, Jennifer;
- Mollan, Katie;
- Hagey, Jill;
- Phiri, Sam;
- Chiwoko, Jane;
- Chinula, Lameck;
- Hosseinipour, Mina C.;
- Cottrell, Mackenzie;
- Pettifor, Audrey;
- Wood, Mollie E.;
- Tang, Jennifer H.
Publication type:
Article
Hepatobiliary Adverse Events Associated With the KRAS p.G12C Inhibitor Sotorasib.
Published in:
Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 2, p. 1, doi. 10.1002/pds.70104
By:
- Frey, Connor
Publication type:
Article
Impact of Lookback Duration on the Performance of a Claims‐Based Frailty Proxy in Women With Stage I–III Breast Cancer.
Published in:
Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 2, p. 1, doi. 10.1002/pds.70103
By:
- Duchesneau, Emilie D.;
- Stürmer, Til;
- Reeder‐Hayes, Katherine;
- Kim, Dae Hyun;
- Edwards, Jessie K.;
- Faurot, Keturah R.;
- Lund, Jennifer L.
Publication type:
Article
Lessons Learned From Characterizing Long COVID Among US Medicare Beneficiaries.
Published in:
Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 2, p. 1, doi. 10.1002/pds.70101
By:
- Lu, Yun;
- Lindaas, Arnstein;
- Izurieta, Hector S.;
- Cozen, Myrna;
- Menis, Mikhail;
- Shi, Xiangyu;
- Steele, Whitney R.;
- Wernecke, Michael;
- Chillarige, Yoganand;
- Kelman, Jeffrey A.;
- Forshee, Richard A.
Publication type:
Article
Validation of Immune‐Related Adverse Event (irAE) Case Definitions in a Real‐World Lung Cancer Population.
Published in:
Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 2, p. 1, doi. 10.1002/pds.70100
By:
- Heyward, James S.;
- Segal, Jodi B.;
- Mehta, Hemalkumar B.;
- Murray, Joseph C.
Publication type:
Article
Quantitative Benefit–Risk Assessment of Vaccination Against COVID‐19: A Systematic Review.
Published in:
Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 2, p. 1, doi. 10.1002/pds.70099
By:
- Newbern, E. Claire;
- Wildisen, Lea;
- Verstraeten, Rita;
- Willame, Corinne;
- Haynes, Kevin;
- Levitan, Bennett;
- Praet, Nicolas
Publication type:
Article
Advancing Research Transparency and Reproducibility in Pharmacoepidemiology.
Published in:
Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 2, p. 1, doi. 10.1002/pds.70096
By:
- Wang, Shirley V.;
- Pottegård, Anton
Publication type:
Article
Use of Potentially Nephrotoxic Drugs in Type 2 Diabetes Patients on SGLT2i: A Trajectories Analysis.
Published in:
Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 2, p. 1, doi. 10.1002/pds.70098
By:
- Yang, Lanting;
- Guo, Jingchuan;
- Kane‐Gill, Sandra L;
- Gabriel, Nico;
- Empey, Kerry M;
- Suh, Kangho;
- Kirisci, Levent;
- Hernandez, Inmaculada
Publication type:
Article
Successful Linkage of Electronic Medical Records and National Health Data System in Type 2 Diabetes Research: Methodological Insights and Implications.
Published in:
Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 2, p. 1, doi. 10.1002/pds.70095
By:
- Goff, Romane Le;
- Brice, Sandrine;
- Contini, Andrea;
- Boussac, Marjorie;
- Souche, Arnaud;
- Belloc, Fabien;
- Coulombel, Nicolas;
- Collin, Cédric;
- Gouverneur, Amandine;
- Molimard, Mathieu
Publication type:
Article
The Clinical Practice Research Datalink (CPRD) Mother–Baby Links: A Data Resource Profile.
Published in:
Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 2, p. 1, doi. 10.1002/pds.70091
By:
- Coton, Sonia;
- Welburn, Stephen;
- Williams, Rachael;
- Campbell, Jennifer
Publication type:
Article
Impact of Pharmacovigilance Interventions Targeting Fluoroquinolones on Antibiotic Use in the Netherlands and the United Kingdom.
Published in:
Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 2, p. 1, doi. 10.1002/pds.70081
By:
- Lasys, Tomas;
- Santa‐Ana‐Tellez, Yared;
- Siiskonen, Satu J.;
- Groenwold, Rolf H. H.;
- Gardarsdottir, Helga
Publication type:
Article
Validation of Clinical Practice Research Datalink (CPRD) Aurum Mother‐Baby Link.
Published in:
Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 2, p. 1, doi. 10.1002/pds.5860
By:
- Vasilakis‐Scaramozza, Catherine;
- Persson, Rebecca;
- Kafatos, George;
- Neasham, David;
- Hagberg, Katrina Wilcox;
- Jick, Susan
Publication type:
Article
Issue Information.
Published in:
Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 2, p. 1, doi. 10.1002/pds.5823
Publication type:
Article